Compound HbS or beta thalassaemia heterozygotes (Q66717): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:32, 14 August 2026
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.)
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_201007614 |
||
| English | Compound HbS or beta thalassaemia heterozygotes |
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.) |
Statements
CID11:ID_201007614
0 references
dki-india-ID_201007614
0 references
Concluído
0 references
13 August 2026
0 references
